T
he US health care system needs to address an unsustainable trajectory of high costs and middling outcomes. The United States has the highest per capita health expenditures in the world but ranks last among developed nations in care quality, efficiency, and equity.
1,2 Recent government health care reforms, including the Patient Protection and Affordable Care Act and the Medicare Access and Children's Health Insurance Program Reauthorization Act (MACRA), aim to improve value.
3,4
The fee-for-service (FFS) payment model contributes to escalating health care expenditures and inconsistent quality.
5-8 Most policymakers believe payment reform is necessary to improve care, and public and private payers are experimenting with a range of payment models that better align payments with value. This review explores existing and emerging payment and delivery reforms that affect cardiologists and considers their definitions and implications for clinical practice (eAppendix in the Supplement). Four examples are described, including a commercial incentive program, an episode payment model, a physician-led accountable care organization (ACO), and a health system participating in multiple models.
MACRA
The MACRA legislation represents the most significant revision of federal health care payment policy in decades. 4 Before MACRA, Medicare FFS payments were adjusted based on the sustainable growth rate formula, in which FFS payment updates were tied to the economy's state. 9,10 Because Medicare spending consistently exceeded economic growth, the sustainable growth rate triggered annual reimbursement cuts. Congress deferred these cuts, but by 2015, compounded deferrals reached 21% and caused uncertainty.
10
MACRA repealed the sustainable growth rate and established a new incentive program.
Payment Models Framework
Payers are moving away from the FFS payment model. The Department of Health and Human Services announced its goal to shift 30% of Medicare payments to alternative payment models (APMs) by 2016 and 50% by 2018, which was met in early 2016, nearly a year ahead of schedule. 11, 12 Commercial payers also aim to tie 75% of payment to value by 2020. 13 The Department of Health and Human Services groups these models into 4 categories, ranging from FFS (category 1) to population-based payment (category 4) ( Table 1) .
14 Payment reforms may affect cardiologists directly-as with the Physician Quality Reporting System 15 and Meaningful Use
16
-or indirectly, as with the Hospital Readmissions Reduction Program. 17 We focus on reforms directed to cardiologists and offer examples in each category.
IMPORTANCE Recent health care reforms aim to increase patient access, reduce costs, and improve health care quality as payers turn to payment reform for greater value. Cardiologists need to understand emerging payment models to succeed in the evolving payment landscape. We review existing payment and delivery reforms that affect cardiologists, present 4 emerging examples, and consider their implications for clinical practice.
OBSERVATIONS Public and commercial payers have recently implemented payment reforms and new models are evolving. Most cardiology models are modified fee-for-service or address procedural or episodic care, but population models are also emerging. Although there is widespread agreement that payment reform is needed, existing programs have significant limitations and the adoption of new programs has been slow. New payment reforms address some of these problems, but many details remain undefined.
CONCLUSIONS AND RELEVANCE Early payment reforms were voluntary and cardiologists' participation is variable. However, conventional fee-for-service will become less viable, and enrollment in new payment models will be unavoidable. Early participation in new payment models will allow clinicians to develop expertise in new care pathways during a period of relatively lower risk.
reimbursement rates for echo and nuclear cardiology services have recently increased, resulting in a large reimbursement difference between clinic-and hospital-based outpatient cardiology practices. The Bipartisan Budget Act of 2015 recognizes this disparity and imposes site-neutral payments on new hospital outpatient departments.
18,19
Commercial payers are also constraining FFS payments. Employers are under pressure to decrease health care expenditures, and people who independently purchase health insurance report the cost as an important factor in plan selection. 20 Because the Patient Protection and Affordable Care Act defines minimal coverage standards, insurers primarily compete on cost. Consequently, commercial insurers have constructed narrow networks of clinicians willing to accept discounted FFS fees. 21 An estimated 39% of networks, 55% of which were in large urban markets, were considered narrow in 2015, and these consistently had lower premiums than broad network plans.
Category 2 (FFS With Links to Quality)
MACRA establishes 2 alternative pathways: the Merit-Based Incentive Payment System (MIPS) and the APM program. Most cardiologists are expected to participate in MIPS (eFigure 1 in the Supplement). 22 The Merit-Based Incentive Payment System combines several existing pay-for-performance programs-Physician Quality Reporting System, Meaningful Use, and Value-Based Modifier-and adds 1 focused on clinical practice improvement. In this combined program, practices will be assigned a composite score composed of 4 categories: quality (50%), resource use (10%), advancing care information (Meaningful Use) (25%), and clinical practice improvement (15%). The relative weighting of these categories will change over time.
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Base physician fee rates will increase by 0.5% per year through 2019 but then will not increase until 2026. In 2017, physicians' composite performance will be calculated and used to adjust FFS payments in 2019. The adjustment magnitude will increase from ±5% in 2019 (performance year 2017) to ±9% in 2022 (performance year 2020) (eFigure 2 in the Supplement).
Category 3 (APMs Built on an FFS Architecture)
Bundled payments are an example of a category 3 payment model. Clinicians receive a lump sum payment for a group of services related to a procedure or care episode instead of individual payments for encounters, services, tests, and procedures. It offers protection from gainsharing rules and improves clinician alignment (eFigure 3 in the Supplement). Participation has been limited because existing models have high upfront costs, reduce reimbursement, add administrative complexity, and introduce conflicting incentives when some patients are in bundles while others remain in FFS. Procedural bundles may be easier to manage than episode bundles, particularly for bundles that cover longer durations. To boost participation, the Centers for Medicare and Medicare Services has established a "facilitator convener" program to provide administrative and technical assistance to participating clinicians. 27 Participating Bundled Payments for Care Improvement Initiative practices often enter these bundled arrangements with goals to develop the knowledge, skills, and infrastructure needed for success before bundles become mandatory. Most current ACOs are also category 3 models. Accountable care organizations are delivery and payment reforms that share accountability for care cost and quality across the health care system. Medicare defines ACOs as "groups of doctors, hospitals, and other healthcare clinicians, who come together voluntarily to give coordinated high quality care." 28 Participation is voluntary for patients and clinicians. In Medicare Shared Savings ACO models, clinicians bill insurers on an FFS basis and outcomes and expenses are compared with regional and national benchmarks. Accountable care organization clinicians who successfully improve quality and reduce costs are eligible to receive bonus payments and shared savings. In ACO models that accept financial risk, ACO clinicians who exceed spending benchmarks may owe money back. Accountable care organizations have steadily increased since 2010, from 64 at the start of 2011 to 838 in 2016. 29 Public and commercial versions exist and they can be health system or physician administered. Early experience with ACOs has been mixed because few have successfully earned performance payments 30 and nearly half of those that did had below-average quality performance. 31 In 2015, the Centers for Medicare and Medicaid
Services announced 18 new Next Generation ACOs that will incorporate "preferred clinicians" to encourage value-driven primary care physician (PCP)-specialist relationships.
29,31
Category 4 (Population-Based Payments)
While the category 2 and category 3 models improve on FFS by incorporating incentives for enhanced value, they remain linked to individual services. For example, bundled payments constrain spending within an episode of care but do not include incentives to limit episode frequency. Accountable care organizations, including most Medicare Shared Savings Programs, continue to pay clinicians on an FFS basis. By decoupling payments from specific services, population models allow clinicians to determine the most effective means of improving health. The Centers for Medicare and Medicaid Services intends to shift clinicians toward population-based payment models that link delivery and payment reforms (categories 3 and 4). The MACRA APM pathway includes category 3 and 4 models, and practices are required to achieve a minimum revenue or patient count threshold to be eligible. MACRA APM participants are exempt from MIPS reporting requirements, receive a 5% bonus through 2024, and have higher base fee rate increases after 2026. 23 Although many practices prefer the APM pathway to MIPS, only 10% of Medicare clinicians are expected to qualify in the first year. Only a few APMs qualify for the pathway; of these, only selected ACO models that accept financial risk and the recently announced Acute Myocardial Infarction and Coronary Artery Bypass Graft bundles 32 are directly pertinent to cardiologists. Blue Cross Blue Shield of Michigan-designated PCMHs are eligible to receive a value-based reimbursement (VBR) of up to 130% of the standard fee schedule for evaluation and management codes. Specialists are eligible for a VBR of up to 110% of the standard fee schedule on most procedure codes. Cardiology VBR is tied to a weighted contribution of several population-level measures, including cost (15%), cost difference from the prior year (10%), an "efficiency" score (30%), a global quality score (30%), and the cost of cardiac diagnostic procedures (15%). To fund the program, statewide physician fees were frozen in 2009; all subsequent fee increases must come through incentive payments.
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The Physician Group Incentive Program is novel in many respects. It shifts the emphasis away from burdensome preauthorization requirements and toward shared accountability for outcomes and costs across a clinician community. Performance feedback comes from 1 of more than 40 physician organizations, and discussions about use and quality occur among peers. Physician organizations nominate specialists to be eligible for VBR, and specialty VBR is based on population-level performance, not practicespecific performance, which means nominated specialists share incentives with their clinical colleagues. A recent analysis showed that PGIP practices had higher performance in 11 of 14 quality measures and 1.1% lower total spending than non-PGIP practices. Building on promising results from prior bundled payment pilots, [45] [46] [47] [48] the Centers for Medicare and Medicaid Services announced the first mandatory APM for cardiac conditions in July 2016. 49 The acute myocardial infarction bundled payment includes hospitalization and all Medicare services in the 90 days following discharge. The model distinguishes between medical and interventional management and accounts for patient complexity (Table 4) . This model takes a "virtual bundling" approach (eg, retrospective reconciliation). 50 The hospital and participating clinicians are paid individual FFS payments at standard Medicare payment rates, but actual expenditures are compared with the target price at the end of each performance year. The target payment amount is determined by a combination of each hospital's historical charges and average regional charges; the target payment is then adjusted for quality performance. Hospitals with charges below the target price may receive incentive payments, but those with charges above may owe money back. Hospitals may align participating clinicians through gainsharing agreements that distribute gains and losses. Strong clinical leadership and substantial investments are needed to successfully redesign care processes, improve quality, and decrease costs. 45 Financial risk increases when hospitals have a low volume of care episodes and a fair distribution of gains and losses between the hospital and independent clinicians may prove contentious. 48 A recent analysis suggests that the bundle will have small effects for most hospitals, but those at the extremes could experience large gains or losses.
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MD Value Care (Category 3 Model)
MD Value Care was established as a physician-led ACO in 2014, and participants expressed a desire to remain independent and succeed in a rapidly changing payment landscape. The ACO participates in Medicare's Shared Savings Program and serves 14 000 beneficiaries. It is composed of 5 PCP groups and 15 specialty practices, including 1 cardiology group in the greater Richmond, Virginia, area. The ACO requires all participants to maintain certified electronic health records. Any shared savings are invested in infrastructure improvements or shared between participating physicians according to a predetermined formula. In physician-led ACOs, the greatest savings opportunities may come from shifting testing and treatment to low-cost settings and avoiding emergency department visits and hospitalizations. Thus, MD Value Care participants have focused on improving communication and coordination, enhancing access to outpatient care, and formalizing comanagement agreements through care compacts. MD Value Care cardiologists have not experienced a negative effect on patient referrals or testing volume and report that ACO participation has expanded their referral base while allowing them to gain experience with APMs (oral communication; Ann Honeycutt, executive director of Virginia Cardiovascular Specialists; July 21, 2016).
In 2014-the only year performance data are available for MD Value Care-the ACO met or exceeded the average ACO performance for most quality measures but accrued 1.8% greater costs than its benchmark. Consequently, it did not receive shared savings in its first year.
52 While large numbers of both physician-and hospitalled ACOs have yet to reach savings benchmarks, more physicianled ACOs have succeeded.
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Henry Ford Physician Network (Multiple Models)
The Henry Ford Physician Network (HFPN) was launched as a commercial ACO (category 3) in 2010 in response to downward pressure on FFS reimbursement and as a strategic initiative to develop value-oriented competencies. 54 The HFPN also participates in PGIP (category 2) and has been selected to participate in Medicare's Next Generation ACO program (category 4). 29 The network comprises 1200 employed physicians in the Henry Ford Medical Group and the Henry Ford Hospital and serves 40 000 to 50 000 covered patients. Unlike earlier Medicare ACO programs, the Next Generation ACO will allow the HFPN to reduce copays for ACO-participating specialists.
Many of the Henry Ford value strategies are administratively driven. To improve system performance, the HFPN has established care registries, implemented case management for frequent users, incorporated electronic health record decision support, and established analytic capabilities to identify and address unwarranted care variations. To simplify the complexity of simultaneous participation in multiple programs (ie, FFS modifiers, PGIP, and the commercial ACO), HFPN has prioritized several performance metrics and incorporated them into physician compensation contracts. Physicians in HFPN are eligible for a 15% incentive tied to productivity, patient satisfaction, and quality metrics. The HFPN has reduced its readmission rate by approximately 10% and achieved savings for 3 consecutive years within its commercial ACO.
Limitations of Existing and Emerging Payment Models
Most policymakers agree that payment reform is needed, but existing models have important limitations. Many cardiologists are unfamiliar with these programs, and bonus payments available in current federal programs may not offset the burden of reporting. 55 Many physicians report that claims-based metrics are unreliable, too general, and delivered too infrequently or too late to be actionable. Within MIPS, proposed process-oriented quality performance measures may not be appropriate for cardiologists who heavily emphasize imaging or interventions. 56 Many hospitals view bundled payments as discounted FFS rather than an opportunity for improved value or gainsharing. While payment models have proliferated, they have not been coordinated across payers, a factor that muddles incentives and increases inefficiency. Primary care physicians increasingly receive feedback on care provided by cardiologists they refer to, but feedback on care quality is limited (if any is offered). These data are intended to incentivize PCPs to refer to lower-cost cardiologists, but PCPs often lack the data necessary to assess value. Further, many PCPs have limited specialty referral options owing to geographic or market factors, or because they are constrained by organizational or insurance considerations. Cardiologists themselves rarely receive actionable feedback on how they might improve.
Payment reform may undermine collaboration if it is perceived as a zero-sum game. Incentives are misaligned when PCPs are paid through APMs while cardiologists remain in FFS. In this scenario, cardiologists lack financial incentives to change. Within ACOs, cardiologists may resist substantial practice changes if shared savings inadequately offset decreased revenues. 57 At the same time, specialists who control high-cost testing and interventions may be best positioned to improve value. Employed cardiologists are often unaware of their APM (or even ACO) participation and performance feedback often goes to the employer, not the cardiologist. They may not perceive changes to their operations or practice if these changes are administratively driven. By contrast, participants in physician-led ACOs may be more engaged in practice improvement because they are directly responsible for operations. Outside of ACOs, the PGIP program is one of the few commercial programs that engages cardiologists in population health, but individual clinicians have little control over population-level outcomes.
Practice Implications
Falling Medicare and commercial FFS payments, the large Medicare FFS payment gradient for imaging services, and the administrative complexity and financial risk of emerging payment models have accelerated hospital acquisitions of cardiology practices. A 2012 survey of 2500 cardiology practices saw hospital ownership triple from 8% to 24% between 2007 to 2012. 58 A 2012 survey among hospital administrators found that 40% acquired or considered acquiring a cardiology practice, and 46% reported that 1 or more cardiology practices were already integrated within their organization.
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By 2013, 53% of cardiology practices reported being fully owned and employed by a hospital, and an additional 25% indicated they were exploring hospital integration. 30,60 A 2016 search of 17 855 American College of Cardiology physician members revealed that at least 67% are employed by health systems. Alternative payment models exist on a spectrum of increasing complexity and financial risk. No single APM will work in every care setting or geographical location. A critical factor in APM participation is how practices are able to administratively manage complex payment structures and assume financial risk. The proportion of revenue derived from APMs must reach a minimum threshold to justify the significant staffing, operational, and administrative changes required for success. 61, 62 Consequently, many independent practices will find category 2 models more feasible, while integrated delivery networks, health systems, and ACOs may more readily participate in more advanced APMs (categories 3 and 4).
Conclusions
The US health care system is in a time of historic change. As the FFS model becomes less viable, participation in APMs will be unavoidable. 12, 63 Cardiologists must understand these emerging models and lead in their development to ensure that they are clinically driven, patient-centered, and avoid unintended consequences such as restricted access to services or a provision of unneeded care. The FFS payment model has often generated perverse incentives, and existing and emerging payment models aim to shift the emphasis from volume to value. Early models have not performed as well as hoped. They have imposed substantial administrative burdens, have not been adequately transparent, and have often not delivered clear incentives at the physician level. New approaches are needed that encourage closer collaboration and coordination across the health system.
Patients are best served when they have continued access to a team of care clinicians with mutually aligned care processes grounded in evidence-based best practice and shared decisionmaking. Ineffective and inefficient care results when PCPs and specialists have differing views on appropriate testing and treatment. To succeed in this new landscape, PCPs and cardiologists need near real-time data on quality and cost performance, and they must closely coordinate care. 
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